Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: A case-control study
Open Access
- 1 January 2001
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 7 (4) , 506-509
- https://doi.org/10.3748/wjg.v7.i4.506
Abstract
AIM: Glutathione S-transferases (GSTs) are involved in the detoxification of many potential carcinogens and appear to play a critical role in the protection from the effects of carcinogens. The contribution of glutathione S-transferases M1 and T1 genotypes to susceptibility to the risk of gastric cancer and their interaction with cigarette smoking are still unclear. The aim of this study was to determine whether there was any relationship between genetic polymorphisms of GSTM1 and GSTT1 and gastric cancer. METHODS: A population based case-control study was carried out in a high-risk area, Changle County, Fujian Province, China. The epidemiological data were collected by a standard questionnaire and blood samples were obtained from 95 incidence gastric cancer cases and 94 healthy controls. A polymerase chain reaction method was used to detect the presence or absence of the GSTM1 and GSTT1 genes in genomic DNA. Logistic regression model was employed in the data analysis. RESULTS: An increase in risk for gastric cancer was found among carriers of GSTM1 null genotype. The adjusted odds ratio (OR) was 2.63 [95% Confidence Interval (95%CI) 1.17-5.88], after controlling for age, gender, cigarette smoking, alcohol drinking, and fish sauce intake. The frequency of GSTT1 null genotype in cancer cases (43.16%) was not significantly different from that in controls (50.00%). However, the risk for gastric cancer in those with GSTM1 null and GSTT1 non-null genotype was significantly higher than in those with both GSTM1 and GSTT1 non-null genotype (OR = 2.77, 95%CI 1.15-6.77). Compared with those subjects who never smoked and had normal GSTM1 genotype, ORs were 1.60 (95%CI: 0.62-4.19) for never smokers with GSTM1 null type, 2.33 (95%CI 0.88-6.28) for smokers with normal GSTM1, and 8.06 (95%CI 2.83-23.67) for smokers with GSTM1 null type. CONCLUSIONS: GSTM1 gene polymorphisms may be associated with genetic susceptibility of stomach cancer and may modulate tobacco-related carcinogenesis of gastric cancer.Keywords
This publication has 35 references indexed in Scilit:
- Helicobacter pyloriand gastric cancer: current status of the Austrain Czech German gastric cancer prevention trial (PRISMA-Study)World Journal of Gastroenterology, 2001
- Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer.2000
- Associations between family history of cancer and genes coding for metabolizing enzymes (United States)Cancer Causes & Control, 2000
- GSTM1, smoking and lung cancer: a case-control studyInternational Journal of Epidemiology, 1999
- Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinomaInternational Journal of Cancer, 1999
- GlutathioneS-transferaseGSTM1, GSTM3, GSTP1 andGSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancersInternational Journal of Cancer, 1999
- Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancerBritish Journal of Cancer, 1998
- Diet and gastric cancer: a case-control study in Fujian Province, ChinaWorld Journal of Gastroenterology, 1998
- Relationship between different sources of drinking water, water quality improvement and gastric cancer mortality in Changle County-A retrospective-cohort study in high incidence areaWorld Journal of Gastroenterology, 1998
- Diet diversity and gastric cancerInternational Journal of Cancer, 1997